Detection & analysis of inflammatory cytokines in tears of patients with lacrimal duct obstruction
- PMID: 35662094
- PMCID: PMC9347244
- DOI: 10.4103/ijmr.IJMR_1435_19
Detection & analysis of inflammatory cytokines in tears of patients with lacrimal duct obstruction
Abstract
Background & objectives: Tear proteomic changes can be a candidate etiopathogenesis of lacrimal duct obstruction diseases (LDODs). Studies on proteomics have focused primarily on nasolacrimal duct obstruction, and some specific inflammatory cytokines such as interferon (IFN)-α2a, interleukin (IL)-8 and IL-10, have not been investigated. In addition, differences in inflammatory cytokines in tears according to the LDOD subtype have not been reported. This study aimed to quantitatively compare inflammatory cytokines in tears from patients with LDOD and investigate tear-cytokine differences among different LDOD subtypes.
Methods: Tear samples were collected from both eyes of 30 patients with unilateral LDOD: five patients with prelacrimal obstruction, five with acute dacryocystitis and 20 with chronic dacryocystitis. The contralateral eyes were used as controls. IFN-α2a, IFN-β, IFN-γ, IL-17A, IL-6, IL-8, tumour necrosis factor-alpha (TNF-α), vascular endothelial growth factor (VEGF)-A, induced protein-10 (IP-10) and monocyte chemotactic protein-1 (MCP-1) were quantified in all samples.
Results: The expression of eight cytokines (except for IP-10 and MCP-1) were significantly increased in the affected eyes compared with those in the control eyes. The levels of nine inflammatory cytokines (except for IP-10) in the affected eyes of patients with chronic dacryocystitis were higher than those in the affected eyes of patients with prelacrimal obstruction. In addition, patients with chronic dacryocystitis presented significantly higher IFN-γ level than those with prelacrimal obstruction or acute dacryocystitis.
Interpretation & conclusions: Specific pro-inflammatory cytokines were increased in tears of patients with LDOD compared with those in the controls. The specific cytokine profiles observed in the tears of individuals with different LDOD subtypes may be associated with the unique aetiopathogenesis of these conditions.
Keywords: Cytokine; epiphora; inflammation; lacrimal duct obstruction; tear.
Conflict of interest statement
Comment in
-
Inflammatory cytokines in tears of patients with lacrimal duct obstruction.Indian J Med Res. 2023 Sep;158(3):317. doi: 10.4103/ijmr.ijmr_1487_22. Indian J Med Res. 2023. PMID: 37815066 Free PMC article. No abstract available.
References
-
- Vinciguerra A, Nonis A, Giordano Resti A, Bussi M, Trimarchi M. Best treatments available for distal acquired lacrimal obstruction: A systematic review and meta-analysis. Clin Otolaryngol. 2020;45:545–57. - PubMed
-
- Das AV, Rath S, Naik MN, Ali MJ. The incidence of lacrimal drainage disorders across a tertiary eye care network: Customization of an indigenously developed electronic medical record system-eyeSmart. Ophthalmic Plast Reconstr Surg. 2019;35:354–6. - PubMed
-
- Ali MJ, Paulsen F. Etiopathogenesis of primary acquired nasolacrimal duct obstruction: What we know and what we need to know. Ophthalmic Plast Reconstr Surg. 2019;35:426–33. - PubMed
-
- Yaginuma S, Konno K, Shigeyasu C, Yamada M. Tear protein analysis in patients with primary acquired nasolacrimal duct obstruction treated with lacrimal passage intubation. Jpn J Ophthalmol. 2021;65:409–15. - PubMed
-
- Ali MJ, Patnaik S, Kelkar N, Ali MH, Kaur I. Alteration of tear cytokine expressions in primary acquired nasolacrimal duct obstruction –Potential insights into the etiopathogenesis. Curr Eye Res. 2020;45:435–9. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials